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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A84the need to remove synovial ﬂuid from the joint. Moreover, measures
of biomarker per particle following the magnetic capture procedure
can be used to estimate total biomarker levels within the joint, a
measure that is less susceptible to the effects of effusion. The purpose
of this study is to demonstrate the ability of magnetic capture to
measure joint-levels of c-telopeptide of type II collagen (CTXII) levels
in a rat OA model.
Methods: Using EDC cross-linking, antibodies against CTXII were
conjugated to carboxyl groups on the surface of 780 nm diameter
polystyrene particles that contained 8.5 nm diameter SPIONs, here-
after referred to as anti-CTXII particles. To assess magnetic capture in
a rat knee, 22 Sprague-Dawley rats (90 days old, male) were acquired.
First, 6 naive rats received an intra-articular injection of 180, 360, or
720 million anti-CTXII particles (n¼4 per knees per group). Next, 8
rats received an intra-articular injection of monoiodoacetate (MIA, 3
mg in 25 mL of saline) with OA allowed to develop over 30 days; the
remaining 8 rats served as age-matched naïve controls for the MIA
animals. For MIA animals and their age-matched naïve controls, 720
million anti-CTXII particles were injected into the knee joint. For all
experiments, injected anti-CTXII particles were allowed to incubate
in the joint for 2 hrs prior to collection. Then, a 1 mm diameter by 1
mm length NdFeB magnet attached to the end of a steel rod was
inserted into the joint space through a 16 gauge catheter. Particles
were collected on the magnet for 10 minutes. Then, the magnet was
removed and washed to isolate particles. Collected particles were
heated to 85C for 3 min, followed by quantiﬁcation of collected
particles and CTXII. CTXII levels in the joint were estimated by
multiplying the ratio of biomarker to particles by the total number of
particles injected. Serum was also collected for CTXII analysis. All
studies were conducted under IACUC-approved protocols. Since the
purpose of this study was to demonstrate feasibility, all magnetic
capture procedures were conducted immediately after humane
euthanasia.
Results:Magnetic capture was able to recover detectable levels of CTXII
from all rat knees. Moreover, estimates of total CTXII levels in the joint
were independent from the number of particles injected (Figure 1a);
thus, a stable estimate of CTXII can be obtained in the rat knee using
post-mortem magnetic capture.
Using magnetic capture, elevated levels of CTXII were detected in
OA-affected joints relative to both contralateral knee and naïve
controls (Figure 1b), while CTXII concentrations in the serum of these
same animals did not yield signiﬁcant differences between MIA-
injected and age-matched naïve control animals (Figure 1c). These
data demonstrate the utility of biomarker assessments in the OA-
affected knee and the ability of magnetic capture to facilitate these
analyses.
Conclusions: Using magnetic capture, signiﬁcant changes in total
CTXII levels were detected in MIA-injected joints using 8 rats per
group. This demonstrates a marked improvement over published lav-
age techniques for the MIA model, where 19-20 animals per group are
often needed to identify signiﬁcant elevations in CTXII concentration
post-lavage. Thus combined, these data demonstrate the feasibility,
stability, and utility of magnetic capture for OA biomarker analysis in
the rat knee.103
QUANTITATIVE PROTEOMICS REVEALS PUTATIVE BIOMARKERS IN
PRE-RADIOLOGICAL OSTEOARTHRITIS
J. Mateos, A. Pintor-Iglesias, P. Fernandez-Puente, S. Rela~no,
I. Rego-Perez, N. Oreiro, C. Fernandez-Lopez, C. Ruiz-Romero,
F.J. Blanco. INIBIC-CHUAC, A Coru~na, Spain
Purpose: In this studywe have identiﬁed proteins differentially abundant
in the serum of Osteoarthritis (OA) patients comparing four different
progressive pathological grades using mass spectrometry and iTRAQ
technique for relative quantiﬁcation. Ourﬁnal aim is to establish a panel of
biomarkers useful to predict thepathology inpre-radiological stages (early
Osteoarthritis biomarkers), but also for its handling and the developing of
trials of treatment in radiological stages (late Osteoarthritis biomarkers).
Methods: 15 individual samples for each condition (OA Grade 0, pre-
radiological stage Grade I, and radiological stage grades II-III and IV)
were pooled in three groups with the aim of reducing the contribution
of individual extreme values. After enrichment in the low-abundant
protein fraction, the pooled samples were subjected to in-solution
digestion, followed by iTRAQ labelling following manufacturer
instructions and Reverse Phase peptide separation in a LC system
(Agilent 1200). Fractions were again separated in a nanoLC system
(Tempo, Eksigent) automatically deposited on a MALDI plate and ana-
lyzed by MSMS in a 4800 MALDI-TOF/TOF system (ABSciex). Relative
quantitative analysis was done using ProteinPilot software (ABSciex)
and modulated proteins were analyzed with String 9.0 software.
Results:We have detected two big sets of serum proteins modulated in
the early pre-radiological OA process. Serum levels of apolipoproteins
are altered when comparing Grade I vs. Grade 0. Speciﬁcally, apolipo-
protein E and apolipoprotein B-100, that mediates the binding, inter-
nalization, and catabolism of lipoprotein particles are accumulated in
Grade I samples. Furthermore, up to six components of the comple-
ment, a group of proteins involved in immune response and inﬂam-
mation are decreased in serum in early OA grades. Among them,
complement component 5 -C5-, that have been recently identiﬁed as
key player of the OA process, is much less abundant in any OA grade in
comparison to Grade 0. Proteins previously described as putative bio-
markers by our group and others, like histidine-rich glycoprotein, gel-
solin and decorin, are also modulated in our study, but at later
radiological stages -Grade II/III and Grade IV vs. Grade I and Grade 0-.
Conclusions: Our results indicate that early pathological grades of the OA
process are linked to an imbalance in the metabolism and, speciﬁcally, in
the lipid metabolism. Altered serum levels of apo-lipoproteins could be
used, in combinationwith other “dry” biomarkers, as an indicator for early
OA process and to detect the pathology in pre-radiological stages. Fur-
thermore, the lower serum levels in the OA grades detected for the com-
plement component 5 -C5-, strongly support recent in vivo data indicating
that a decrease of this protein is linked to the development of the disease.104
STATUS OF OXIDATIVE STRESS BIOMARKERS IN OSTEOARTHRITIS
PATIENTS IN NORTH INDIAN POPULATION
S. Srivastava y, A.K. Saksena y, S. Khattri y, S. Kumar z, R.S. Dagur x. yDept.
of Pharmacology& Therapeutics, King George's Med. Univ., Lucknow, India;
zDept. of Orthopedic Surgery, King George's Med. Univ., Lucknow, India;
xAdvancedMolecular Sci. Res. Ctr., King George's Med. Univ., Lucknow, India
Purpose: Osteoarthritis (OA) is the most common type of arthritis in
which there is membrane / cartilage destruction leading to bone
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A85deformities in severe cases. Simultaneously, there is generation of more
oxidative stress biomarkers such as Reactive Oxygen species (ROS) and
Malondialdehyde (MDA), which is the major reactive aldehyde pro-
duced due to peroxidation of lipids present in biological membranes.
We, therefore, investigated the status of oxidative stress quantiﬁed in
terms of MDA and ROS in serum and lymphocytes, respectively, in
patients of OA of knee and correlated the levels of biomarkers with
different radiological grades of the disease.
Methods: After obtaining ethical clearance 80 patients, who were suf-
fering from OA of knee were enrolled according to the inclusion /
exclusion criteria described by ‘The American College of Rheumatology’.
Informed consent was taken from all patients and blood samples along
with the radiographs of the knee joints were obtained. These patients
were subdivided into four groups according to severity of the disease
using Kellgren-Lawrence (KL) grading scale and were also analysed for
assessment of pain by using Visual Analogue Scale (VAS).
The blood samples were processed to get serum for estimation of MDA
using thiobarbituric acid reactive substances assay. ForROSmeasurement,
lymphocytes were isolated from the blood sample using density gradient
histopaque solution. These lymphocytes were incubated with 2, 7-
dichloroﬂuorescein diacetate (DCF-DA) dye for 30 minutes and then
acquisition was done on Image Stream X Mark II ﬂow cytometer (AMNIS
Corporation, Seattle) andanalysiswasdoneusing IDEASanalysis software.
Results: We found that the levels of both ROS and MDA in KL-grade III
and IV patients were signiﬁcantly higher (p<0.05) as compared to the
levels of these biomarkers in KL-grade I and II. Further, it was also
observed that although the level of both biomarkers was more in KL-
grade IV than in KL-grade III but the difference was not signiﬁcant. The
VAS score was found to be highest in KL-grade IV patients as compared
to the other three groups.
Conclusions: The study indicates that progression of OA of knee gen-
erates more ROS and causes more lipid peroxidation, thus exhibiting
more oxidative stress in patients. Hence, it may be proposed that the
levels of ROSandMDAarewell correlatedwithprogression ofOAof knee.
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THE LOWER CARTILAGE SYNTHESIS, BUT NOT HIGHER CARTILAGE
DESTRUCTION, IS ASSOCIATED WITH THE KNEE JOINT SPACE
WIDTH IN MEN IN EARLY FORTIES WITHOUT KNEE PAIN
M. Kinoshita y, H. Kaneko y, L. Lui y,z, R. Sadatsuki y, S. Hada y,
Y. Shimura y, M. Tsuchiya x, A. Yusup y, I. Futami x, Y. Tamura z,
H. Watada z, R. Kawamori z, K. Kaneko y,z, M. Ishijima y,z. yDept. of Med.
for Orthopaedics and Motor Organ, Juntendo Univ. Graduate Sch. of Med.,
Tokyo, Japan; z Sportology Ctr., Juntendo Univ. Graduate Sch. of Med.,
Tokyo, Japan; xDept. of Orthopaedics, Juntendo Metropolitan Koto
Geriatric Med. Ctr., Tokyo, Japan; kDept. of Med. for Orthopaedics and
Motor Organ, Juntendo Univ. Graduate Sch. of Med., Tokyo, Japan
Purpose: The prevalence of knee osteoarthritis (OA) is peaked at around
ﬁfty years of age in worldwide (Global Burden of the Disease 2010).
However, it has been recently considered that the knee OA is initiated
much younger than ﬁfty years of age and proceeded asymptomatically
for a long time. As OA is primarily an age-related degenerative disease of
articular cartilage, the radiographic joint space width (JSW) is gradually
narrowed and the OA incidence is deﬁned by the joint space narrowing.
However, it is poorly understood how the asymptomatic phase of pri-
mary kneeOA is proceeded. Several cartilage biomarkers have cultivated
as a sensitive diagnostic tool for knee OA. Pro-collagen type II C-pro-
peptide (PIICP) is a major articular cartilage constituent and reﬂects the
rate of type II procollagen synthesis. The collagen type II cleavage (C2C)
and cross-inked type II collagen C-telopeptide (CTX-II) are produced in
the course of degradation of type II collagen. It has been believed that
knee OA is primarily characterized by cartilage degradation. We pre-
viously reported that the these biomarkers in the primary knee OA
patients (K/L grade 1 and 2) with knee pain were all signiﬁcantly
increased in comparison to those without knee pain. In K/L grade 1
patients both sC2C and sCPII were increased in those with knee pain.
However, among the K/L grade 2 patients, only uCTX-II was increased
and in those with knee pain. In addition, sCPII levels of K/L grade 1
patientswithout kneepainwasdecreased in thoseofK/L grade2patients
without knee pain, while no signiﬁcant changes of the sC2C and uCTX-II
levels were observed in between K/L grade 1 and 2. In the present study,
we examined the interrelationships between the cartilage metabolism
and the knee articular cartilage thickness of the healthy subjects at
around forty years of age without knee pain using biomarkers.Methods: Sixty-three healthy men volunteers (41.7y in average) were
enrolled in this study. Thesubjectsdidn’thaveanysymptoms forkneepain
and experience any traumatic episodes for their knee joints. The standing,
extended antero-posterior view and the postero-anterior weight-bearing
radiograph made with the knee in 45 of ﬂexion (Rosenberg radiograph)
were taken for both knees and serum levels of PIICP and C2C and urinary
level of CTX-II were also measured at the time of study entry. These car-
tilage biomarkers were measured by ELISA (PIICP; Uscn life science, C2C
IBEX, CTX-II; ids). The JSWof the knee joint was determined at the center
point of the medial femoro-tibial compartment on a radiograph using a
0.1-mm graduated magnifying lens. For each participant, the higher K/L
grade and the lower JSWof theﬁndings of both knees used for the analysis
as targeted knee. The statistical analyses were conducted using the SPSS
(SPSS version 17.0). The correlation between every particular objectswere
assessed by Spearman’s rank-correlation coefﬁcient. Relationship
between JSW and several targeted cartilage biomarker were assessed by
single correlation analysis with adjustment for age and body mass index
(BMI). Furthermore in order to ﬁnd outwhich cartilage biomarkermay be
most inﬂuent to JSW, relationships between JSWand all targeted cartilage
biomarkers were assessed by multiple linear regression analysis (Step
Wise) with adjustments for age and BMI.
Results:Of 63 subjects, seventeen, thirty-nine and seven showed the K/L
grade 0,1 and 2 on radiographs, respectively. The serum average level of
PIICPs was 327.44 pg/mL (SD; 239.37), the serum average level of C2Cs
was 82.51 mg/mL (18.05), the urinary average level of CTX-II was 316.53
ng/mmol (290.51) and the JSW in the targeted knee was 4.65 mm on
average (0.96). The JSW was normally distributed. The sC2C and sPIICP
were positively correlated (b¼0.336, p¼0.022), while sC2C and uCTX-II
(b¼0.010, p¼0.953) and uCTX-II and sPIICP were not correlated (b¼-
0.081, p¼0.619). The JSW was positively correlated with both sPIICP
(b¼0.348, p¼0.011) and sC2C (b¼0.333, p¼0.011), respectively, while no
correlation between the JSW and uCTX-II was observed (b¼-0.0239,
p¼0.123). Themultiple linear regression analysis showed that sPIICPwas
the factor that positively correlated with the JSW (b¼0.474, p¼0.001).
Conclusions: We demonstrated that both cartilage synthesis marker
(PIICP) and degradation marker (C2C) are associated with the JSWof the
asymptomatic knee of the healthy subjects at around forty years of age.
We also demonstrated that the lower cartilage synthesis was most
strongly associated with JSW in men in early forties.
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CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) LEVELS IN
SERUM AND SYNOVIAL FLUID IN OSTEOARTHRITIS (OA) PATIENTS:
CORRELATION WITH CLINICAL, RADIOLOGICAL AND LABORATORY
PARAMETERS
T.A. Gheita y, A.H. El-Awar y, M.M. El-Ansary z, H.M. Raslan x,
A.O. El-Defrawy x. yRheumatology Dept., Faculty of Med., Cairo Univ.,
Cairo, Egypt; zClinical Pathology Dept., Faculty of Med., Cairo Univ.,
Cairo, Egypt; x Internal Med. Dept., Natl. Res. Ctr., Egypt, Cairo, Egypt
Purpose: The aim of the study is to assess the cartilage oligomeric
matrix protein (COMP) levels in serum and synovial ﬂuid in osteo-
arthritis (OA) patients and to correlate the levels with clinical, radio-
logical and laboratory parameters.
Methods: 23 OA patients were included. Thorough history taking and
clinical examination were performed. Serum and synovial COMP were
determinedbyELISA.Osteoarthritis severitywasassessedaccording to the
Kellgren-Lawrence (KL) scale.Patientswere subgrouped intoearlyand late
OA according to the presence of knee destruction (grades 3 KL scale).
Results: The mean age of the patients was 45±12.9 years. 9 had con-
comitant knee effusion. The KL scale was signiﬁcantly higher in patients
with established (3.4±0.5) compared to those with early OA (1.7±0.5).
The serum COMPwas signiﬁcantly higher in the OA patients (27±10 mg/
ml) compared to the control (5.4±2mg/ml) (p<0.00001). In synovial
ﬂuid it was even higher (59.1±11.4mg/ml). Serum and synovial levels
were higher in established compared to early cases. Serum and synovial
levels signiﬁcantly correlated with the age, body mass index, disease
duration and KL grade.
Conclusions: Assay of COMP in serum/synovial ﬂuid could mirror the
process of articular damage in OA patients. Promisingly, COMP levels have
the potential to be reliable diagnostic markers in the assessment of early
joint destruction in and can guide to predict the disease outcome for rapid
treatment initiation in patients at early stages. Levels correlated with
radiological jointdamagebut notwithclinical diseaseparameters, thus can
be used for monitoring the response to different therapeutic modalities.
